Immunophenotypic characteristics of LMO2-rearranged pediatric T-ALL patients
. | . | Positive cells, % . | . | . | . | . | . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient ID . | LMO2 rearrangement . | CD34 . | CD33 . | CD1 . | CD4 . | CD8 . | cytCD3 . | mCD3 . | TCRαβ . | |||||||
| 1950 | del(11)(p12p13) | 0 | 0 | 0 | 85 | 91 | 90 | 80 | Pos | |||||||
| 2846 | del(11)(p12p13) | 0 | 10 | 0 | 48 | 57 | 75 | 26 | Neg | |||||||
| 2104 | del(11)(p12p13) | 0 | 0 | 0 | 6 | 1 | 98 | 45 | Pos | |||||||
| 2698 | t(11;14)(p13;q11) | 1 | 8 | 0 | 42 | 69 | 93 | 3 | Neg | |||||||
| 2789 | t(11;14)(p13;q11) | 1 | 12 | 25 | 59 | 73 | 85 | 12 | Neg | |||||||
| 2735 | t(11;14)(p13;q11) | 4 | 1 | 71 | 90 | 94 | 82 | 8 | Neg | |||||||
. | . | Positive cells, % . | . | . | . | . | . | . | . | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient ID . | LMO2 rearrangement . | CD34 . | CD33 . | CD1 . | CD4 . | CD8 . | cytCD3 . | mCD3 . | TCRαβ . | |||||||
| 1950 | del(11)(p12p13) | 0 | 0 | 0 | 85 | 91 | 90 | 80 | Pos | |||||||
| 2846 | del(11)(p12p13) | 0 | 10 | 0 | 48 | 57 | 75 | 26 | Neg | |||||||
| 2104 | del(11)(p12p13) | 0 | 0 | 0 | 6 | 1 | 98 | 45 | Pos | |||||||
| 2698 | t(11;14)(p13;q11) | 1 | 8 | 0 | 42 | 69 | 93 | 3 | Neg | |||||||
| 2789 | t(11;14)(p13;q11) | 1 | 12 | 25 | 59 | 73 | 85 | 12 | Neg | |||||||
| 2735 | t(11;14)(p13;q11) | 4 | 1 | 71 | 90 | 94 | 82 | 8 | Neg | |||||||
cytCD3 indicates cytoplasmic CD3; mCD3, membrane CD3; Pos, positive; and Neg, negative